Cited by 401Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on BehaviorOpioid Use Disorder Treatment

New findings on biological factors predicting addiction relapse vulnerability

Open access
Sinha, Rajita·2011·Current Psychiatry Reports

Abstract

Relapse is a highly prevalent phenomenon in addiction. This paper examines the new research on identifying biological factors that contribute to addiction relapse risk. Prospective studies examining relapse risk are reviewed, and clinical, biological, and neural factors that predict relapse risk are identified. Clinical factors, patient-related factors, and subjective and behavioral measures such as depressive symptoms, stress, and drug craving all predict future relapse risk. Among biological measures, endocrine measures such as cortisol and cortisol/corticotropin (ACTH) ratio as a measure of adrenal sensitivity and serum brain-derived neurotrophic factor were also predictive of future relapse risk. Among neural measures, brain atrophy in the medial frontal regions and hyperreactivity of the anterior cingulate during withdrawal were identified as important in drug withdrawal and relapse risk. Caveats pertaining to specific drug abuse type and phase of addiction are discussed. Finally, significant implications of these findings for clinical practice are presented, with a specific focus on determining biological markers of relapse risk that may be used to identify those individuals who are most at risk of relapse in the clinic. Such markers may then be used to assess treatment response and develop specific treatments that will normalize these neural and biological sequelae so as to significantly improve relapse outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11920-011-0224-0

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sinha, R.
Affiliations
Yale University (US)
Corresponding author
Sinha, Rajita
Venue
Current Psychiatry Reports
Published
2011-07-27
Volume
13
Issue
5
Pages
398-405
ISSN
  • 1523-3812 (ISSN-L)
  • 1535-1645
OpenAlex
W2136772960
Cited by
401
References
100
Citations by year
2026: 29 · 2025: 38 · 2024: 41 · 2023: 49 · 2022: 38 · 2021: 40 · 2020: 39 · 2019: 33 · 2018: 24 · 2017: 11 · 2016: 10 · 2015: 15 · 2014: 15 · 2013: 13 · 2012: 6
FWCI
1.28
Type
journal article
Language
en
Open access
Locations
  • Current Psychiatry Reports (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (R01AA013892, R01-AA-13892)
  • National Institute on Drug Abuse (P50-DA165556, R01-DA27230, PL1DA024859)
  • National Institute of Dental and Craniofacial Research (UL1-DE019589)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
addiction relapse, relapse risk prediction, biomarkers, drug craving, depressive symptoms, stress, cortisol, ACTH, brain-derived neurotrophic factor, brain atrophy, drug withdrawal, neural factors, hormonal factors
MeSH terms
Adrenocorticotropic Hormone, Humans, Hydrocortisone, Predictive Value of Tests, Prospective Studies, Recurrence, Biomarkers, Brain-Derived Neurotrophic Factor, Substance-Related Disorders, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review